Your browser doesn't support javascript.
loading
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia.
Schlenk, R F; Frech, P; Weber, D; Brossart, P; Horst, H-A; Kraemer, D; Held, G; Ringhoffer, M; Burchardt, A; Kobbe, G; Götze, K; Nachbaur, D; Fischer, T; Lübbert, M; Salih, H R; Salwender, H; Wulf, G; Koller, E; Wattad, M; Fiedler, W; Kremers, S; Kirchen, H; Hertenstein, B; Paschka, P; Gaidzik, V I; Teleanu, V; Heuser, M; Thol, F; Döhner, K; Krauter, J; Ganser, A; Döhner, H.
Affiliation
  • Schlenk RF; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Frech P; NCT Trial Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Weber D; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Brossart P; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Horst HA; Department of Internal Medicine III, University Hospital of Bonn, Bonn, Germany.
  • Kraemer D; Department of Internal Medicine II, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Held G; Department of Oncology and Hematology, Klinikum Oldenburg, Oldenburg, Germany.
  • Ringhoffer M; Department of Internal Medicine I, University Hospital of Saarland, Homburg, Germany.
  • Burchardt A; Department of Internal Medicine III, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • Kobbe G; Department of Hematology/Oncology, University-hospital Giessen, Giessen, Germany.
  • Götze K; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Nachbaur D; Department of Internal Medicine III, Technical University of Munich, Munich, Germany.
  • Fischer T; Department of Internal Medicine V, University Hospital Innsbruck, Innsbruck, Austria.
  • Lübbert M; Department of Medicine III, Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Salih HR; Department of Hematology and Oncology, University Hospital of Freiburg, Freiburg, Germany.
  • Salwender H; Department of Hematology and Oncology, Eberhard-Karls University, Tübingen, Germany.
  • Wulf G; Department of Hematology/Oncology, Asklepios Klinik Altona, Hamburg, Germany.
  • Koller E; Department of Hematology and Oncology, University Hospital of Göttingen, Göttingen, Germany.
  • Wattad M; Department of Hematology/Oncology, Hanuschkrankenhaus, Wien, Austria.
  • Fiedler W; Department of Hematology Oncology, Kliniken Essen-Süd, Essen, Germany.
  • Kremers S; Department of Internal Medicine II, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kirchen H; Department of Hematology/Oncology, Caritas-Krankenhaus, Lebach, Germany.
  • Hertenstein B; Department of Hematology/Oncology, Krankenhaus der Barmherzigen Brüder, Trier, Germany.
  • Paschka P; Department of Internal Medicine I, Klinikum Bremen Mitte, Bremen, Germany.
  • Gaidzik VI; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Teleanu V; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Heuser M; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Döhner K; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Krauter J; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Döhner H; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Leukemia ; 31(5): 1217-1220, 2017 05.
Article in En | MEDLINE | ID: mdl-28096533

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Salvage Therapy Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Salvage Therapy Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Germany